| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_RP5-977B1.7_0001000 | Intron-Intron | chr20:35147664-35148281 | chr20:36519261-36519878 | 618 nt | 0.3916 |
| hsa_RP5-977B1.7_0001100 | Intron-Intron | chr20:35151594-35151815 | chr20:36523191-36523412 | 222 nt | 0.4144 |
| hsa_RP5-977B1.7_0001200 | Intron-Intron | chr20:35155425-35155699 | chr20:36527022-36527296 | 275 nt | 0.3927 |
| hsa_DLGAP4_0000100 | Intron-Intron | chr20:34958069-34959168 | chr20:36329666-36330765 | 1100 nt | 0.4909 |
| hsa_DLGAP4_0000200 | Intron-Exon-Intron | chr20:34970375-34995678 | chr20:36341972-36367275 | 105 nt | 0.6000 |
| hsa_DLGAP4_0000300 | Intron-Intron | chr20:34984249-34990006 | chr20:36355846-36361603 | 250 nt | 0.4600 |
| hsa_DLGAP4_0000400 | Intron-Exon-Intron | chr20:34989874-34995678 | chr20:36361471-36367275 | 250 nt | 0.4840 |
| hsa_DLGAP4_0000500 | Exon-Intron | chr20:34995448-35026719 | chr20:36367045-36398316 | 119 nt | 0.5126 |
| hsa_DLGAP4_0000600 | Intron-Intron | chr20:35003492-35006639 | chr20:36375089-36378236 | 250 nt | 0.4760 |
| hsa_DLGAP4_0001000 | Intron-Intron | chr20:35003887-35026719 | chr20:36375484-36398316 | 113 nt | 0.4956 |
A study in mice and humans demonstrated that the circDLGAP4 is significantly decreased in plasma after acute ischemic stroke and in a mouse stroke model, suggesting its potential as a therapeutic target for myocardial ischemia/reperfusion injury [Tian et al. DOI:10.3390/molecules26041155].